| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |